These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9855417)

  • 1. Epidemiological factors in clinical trial design.
    Wassilak S
    Dev Biol Stand; 1998; 95():75-83. PubMed ID: 9855417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phased approach to clinical testing: criteria for progressing from Phase I to Phase II to Phase III studies.
    André FE; Foulkes MA
    Dev Biol Stand; 1998; 95():57-60. PubMed ID: 9855414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials.
    Farrington P; Miller E
    Methods Mol Med; 2003; 87():335-52. PubMed ID: 12958466
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring and safety assessment in Phase I to III clinical trials.
    Fescharek R; Nicolay U; Arras-Reiter C
    Dev Biol Stand; 1998; 95():203-9. PubMed ID: 9855433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing phase III or IV trials for vaccines: choosing between individual or cluster randomised trial designs.
    Vaucher P
    Vaccine; 2009 Mar; 27(13):1928-31. PubMed ID: 19368773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field assays with anti-malarial vaccines: phase III protocols.
    Sanchez T
    Rev Inst Med Trop Sao Paulo; 1992 Apr; 34 Suppl 9():S24-7. PubMed ID: 1340629
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the enoximone clinical trials program.
    Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
    J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine efficacy determination.
    Broome CV
    NIPH Ann; 1991 Dec; 14(2):219-21; discussion 222-4. PubMed ID: 1812435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality.
    Manzoli L; Schioppa F; Boccia A; Villari P
    Pediatr Infect Dis J; 2007 Feb; 26(2):97-106. PubMed ID: 17259870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pitfalls of field trials in fish vaccinology.
    Mitchell H
    Dev Biol Stand; 1997; 90():321-32. PubMed ID: 9270860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 13. Statistical aspects of fish vaccination trials.
    Jarp J; Tverdal A
    Dev Biol Stand; 1997; 90():311-20. PubMed ID: 9270859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring protection: efficacy versus effectiveness.
    Fedson DS
    Dev Biol Stand; 1998; 95():195-201. PubMed ID: 9855432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic vaccine trails in Thailand.
    Churdboonchart V
    J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical safety evaluation of combination vaccines.
    Midthun K; Horne AD; Goldenthal KL
    Dev Biol Stand; 1998; 95():245-9. PubMed ID: 9855438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
    Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
    Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy: clinical trials--optimal trial and clinical outcomes.
    Bousquet PJ; Demoly P; Passalacqua G; Canonica GW; Bousquet J
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):561-6. PubMed ID: 17989535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.